Compare LLYVA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLYVA | CORT |
|---|---|---|
| Founded | 1991 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.7B |
| IPO Year | 2025 | 2001 |
| Metric | LLYVA | CORT |
|---|---|---|
| Price | $93.66 | $115.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $96.50 |
| AVG Volume (30 Days) | 93.0K | ★ 710.8K |
| Earning Date | 02-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $381,951,000.00 | ★ $761,407,000.00 |
| Revenue This Year | N/A | $26.08 |
| Revenue Next Year | $5.52 | $26.98 |
| P/E Ratio | ★ N/A | $1,266.44 |
| Revenue Growth | 12.18 | ★ 12.79 |
| 52 Week Low | $74.38 | $28.66 |
| 52 Week High | $106.06 | $126.38 |
| Indicator | LLYVA | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 54.91 |
| Support Level | $93.31 | $77.73 |
| Resistance Level | $99.16 | $124.30 |
| Average True Range (ATR) | 2.12 | 4.69 |
| MACD | -0.93 | -1.43 |
| Stochastic Oscillator | 3.97 | 37.39 |
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.